Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Pentraxin 3 and Cathepsin B Levels in the Second Trimester in Predicting of Maternal and Fetal Results in Preeclamptic Pregnancy

NCT05924061 is registered in ClinicalTrials.gov with Sanliurfa Mehmet Akif Inan Education and Research Hospital as lead sponsor.

NCT NCT05924061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05924061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Pentraxin 3 and Cathepsin B Levels in the Second Trimester in Predicting of Maternal and Fetal Results in Preeclamptic Pregnancy
Lead sponsor
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
December 31, 2022
Enrollment
156 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cathepsin b level, pentraxin 3 level, pre-eclampsia